An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).
An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).
复制标题
DOI：
10.4172/2155-6105.1000324
复制
发表时间：
2017-01-01
期刊：
影响因子：
--
通讯作者：
Sonje, Snezana
中科院分区：
文献类型：
--
作者：
Kumari, Suneeta;Malik, Mansoor;Sonje, Snezana
测量精神分裂症阳性症状和阴性症状的量表仍然是临床医生和研究人员评估和诊断精神分裂症的主要方式。该量表主要用于监测精神分裂症患者阳性和阴性症状的严重程度，并跟踪治疗反应。虽然这些量表被广泛使用，但每个量表的质量和一般用途各不相同。量表的效度和信度决定了量表的质量。该量表的效用由给药时间和可在研究或临床环境中实施该量表的环境决定。与旧版PANSS(阳性和阴性症状评定量表)、SAPS(阳性症状评定量表)、SANS(阴性症状评定量表)、NSA-16(阴性症状评定量表)和CGI-SCH(临床总体印象精神分裂症)进行比较的较新量表，如CAINS(阴性症状临床评估访谈)和BNSS(简明阴性症状量表)的文章相对较少。较老的天平是在30多年前开发出来的。从那时起，我们对阴性症状的理解发生了变化，目前有了新的评分表来评估阴性症状的有效性。较旧的量表没有纳入关于阴性症状的最新研究。CAINS和BNSS因其信度和简明易懂的形式而颇具吸引力，然而，一种更简单、易懂、用户友好的量表，纳入了精神分裂症的多维模型，解决了心理社会和认知因素，尚未开发。
Scales measuring positive and negative symptoms in schizophrenia remain the primary mo Scales measuring positive and negative symptoms in schizophrenia remain the primary mode of assessing and diagnosing schizophrenia by clinicians and researchers. The scales are mainly used to monitor the severity of positive and negative symptoms and track treatment response in schizophrenics. Although these scales are widely used, quality as well as general utility of each scale varies. The quality is determined by the validity and reliability of the scales. The utility of the scale is determined by the time of administration and the settings for which the scales can be administered in research or clinical settings. There are relatively fewer articles on the utility of newer scales like CAINS (Clinical Assessment Interview for Negative Symptoms) and the BNSS (Brief Negative Symptom Scale) that compare them to the older scales PANSS (Positive and Negative Symptoms Scale), SAPS (Scale for the Assessment of Positive Symptoms) SANS (the Scale for the Assessment of Negative Symptoms), NSA-16 (Negative Symptom Assessment-16) and CGI-SCH (Clinical Global Impression Schizophrenia. The older scales were developed more than 30 years ago. Since then, our understanding of negative symptoms has evolved and currently there are newer rating scales evaluating the validity of negative symptoms. The older scales do not incorporate the latest research on negative symptoms. CAINS and BNSS are attractive for both their reliability and their concise accessible format, however, a scale that is simpler, accessible, user-friendly, that incorporates a multidimensional model of schizophrenia, addresses the psychosocial and cognitive component has yet to be developed.